Premature infants, defined as those born before the completion of 37 weeks of gestation, face numerous health challenges, including susceptibility to infections and developmental delays. Among the most significant variables influencing their recovery and development during the vulnerable neonatal period is the type of nutritional support they receive. Human milk, especially donor milk, is often considered the gold standard due to its immunological and bioactive properties, though concerns about its ability to support optimal growth have persisted.

The MILK Trial is distinctive in design and scope. It randomized a cohort of preterm infants to receive either pasteurized donor human milk or preterm formula from the early days post-birth until discharge. Subsequently, the researchers conducted a longitudinal follow-up assessing growth parameters at two years of adjusted age, thereby enabling an understanding of not only immediate but also longer-term growth outcomes.

The fundamental hypothesis posited by the investigators was that there would be no significant differences in the anthropometric growth measures—weight, length, and head circumference—at the two-year follow-up, regardless of whether infants were fed donor milk or formula. This hypothesis emerged from prior, smaller studies suggesting equivalent growth patterns but lacked the statistical power to conclude definitively.

Upon evaluation, the data demonstrated that infants fed donor milk achieved growth metrics that paralleled their formula-fed counterparts at two years, thereby affirming the original hypothesis. Notably, these findings suggest that donor milk is a viable alternative to preterm formula without compromising growth in the critical early developmental window. This revelation challenges lingering biases favoring formula on the basis of growth promotion.

The trial meticulously accounted for confounding variables that could independently impact growth, including gestational age at birth, severity of neonatal complications, socioeconomic status, and access to post-discharge nutritional support. Adjusted analyses reinforced the robustness of the conclusion, underscoring that neonatal diet type itself did not differentially affect growth trajectories by the endpoint.

Importantly, the implications of these results extend beyond mere anthropometrics. Donor milk confers immunological benefits absent in formula, such as the transfer of maternal antibodies and prebiotic components that modulate the infant gut microbiome. The reassuring evidence of equal growth dispels concerns that opting for donor milk entails a trade-off between immunity and somatic growth, an issue that has long vexed neonatologists and dietitians.

While the infant brain’s development heavily relies on adequate nutrition, head circumference – a proxy for brain growth – was statistically indistinguishable between the two nutritional cohorts. This aspect addresses critical developmental concerns, broadly suggesting that donor milk supports neurodevelopmental programming as effectively as formula feeding under these controlled conditions.

These findings resonate strongly with ongoing efforts to optimize neonatal nutrition protocols, particularly within neonatal intensive care units (NICUs) where premature infants are managed. Donor milk banking systems, which have expanded globally, now gain further empirical justification as an essential resource that combines safety, nutrition, and ethical viability.

Furthermore, the trial’s follow-up at two years provides invaluable insight into medium-term developmental outcomes, extending the window of observation well beyond the initial hospitalization period. This approach illustrates the importance of longitudinal studies in neonatal nutrition research to capture the full spectrum of growth and developmental dynamics.

This rigorous clinical evidence is poised to inform clinical guidelines and policy decisions, potentially increasing advocacy for the use of donor milk in NICUs, reducing reliance on formula, and ultimately improving neonatal care standards. It also offers reassurance to parents grappling with feeding decisions in high-stress neonatal contexts.

Moreover, by conclusively demonstrating no deleterious growth impact attributable to donor milk, the MILK Trial opens avenues for exploring additional benefits donor milk may provide, such as reduced incidence of necrotizing enterocolitis and other inflammatory conditions prevalent in preterm infants.

The significance of these findings is amplified by the careful methodological rigor evident in the trial’s design, including randomization, blinding of assessors, and standardized growth measurement protocols, which collectively strengthen the validity and reliability of the conclusions drawn.

Future research inspired by these results may delve into nuanced nutritional compositions of donor milk, including fortification strategies aimed at optimizing macronutrient balance to further enhance both growth and functional outcomes.

In sum, the NICHD Neonatal Research Network’s MILK Trial constitutes a landmark study in neonatal nutrition, affirming that feeding preterm infants donor human milk achieves growth outcomes comparable to those observed with preterm formula. This evidence supports a paradigm shift in neonatal feeding practices, emphasizing the non-inferiority of donor milk with respect to growth, alongside its well-documented immunological advantages.

As the neonatal care community digests these findings, there is potential for widespread transformation in how vulnerable preterm infants are nourished during their most critical developmental phase. The MILK Trial’s robust evidence base will likely catalyze changes benefiting countless infants and families worldwide, underscoring that early nutrition remains central to lifelong health trajectories.

Subject of Research: Growth outcomes at two years of age in preterm infants based on neonatal diet: donor human milk versus preterm formula.

Article Title: Growth at 2 years in children born preterm: donor milk versus preterm formula.

Article References:
Brumbaugh, J.E., McDonald, S.A., Robinson, D.T. et al. Growth at 2 years in children born preterm: donor milk versus preterm formula. Pediatr Res (2026). https://doi.org/10.1038/s41390-025-04729-z

Image Credits: AI Generated

DOI: 19 January 2026

Preterm birth, defined as birth before 37 weeks of gestation, poses significant risks for neurological impairments due to the interruption of critical brain growth phases that typically occur in the third trimester. Infants born very preterm, usually before 32 weeks, face heightened risks of cognitive, motor, and behavioral disorders later in life. The brain’s rapid development during this period makes it exceptionally sensitive to external influences, including nutritional intake.

This new investigation aimed to assess the differential effects of donor human milk versus formula feeding on the brain structure of very preterm infants, employing advanced neuroimaging techniques to provide detailed insights. Donor human milk, obtained from screened lactating individuals and pasteurized to ensure safety, has been known to supply essential nutrients and bioactive factors absent in formula yet widely utilized in neonatal intensive care units (NICUs) worldwide when the infant’s own mother’s milk is unavailable.

Utilizing quantitative magnetic resonance imaging (MRI) methods, the research team observed significant differences in brain volumes and white matter integrity among infants fed with donor human milk compared to those fed formula. These neuroimaging biomarkers serve as proxies for neurological health and maturation, reflecting the extent and quality of brain development. The methodology included precise volumetric analyses of cortical and subcortical structures, as well as diffusion tensor imaging (DTI) to assess microstructural development.

Remarkably, infants receiving donor human milk exhibited greater total brain volume and enhanced microstructural integrity of white matter tracts vital for cognitive and motor functions, compared to their formula-fed counterparts. These findings suggest that donor milk confers neuroprotective benefits that may translate into improved developmental trajectories, potentially mitigating some adverse effects associated with prematurity.

The study’s design carefully controlled for confounding variables such as gestational age at birth, birth weight, and exposure to neonatal morbidities, ensuring that observed differences were attributable primarily to nutritional intake. This rigorous approach lends robustness to the conclusions, emphasizing the intrinsic value of human milk components beyond mere caloric content.

Exploring the underlying biological mechanisms, donor human milk contains numerous bioactive elements such as growth factors, immunoglobulins, enzymes, and anti-inflammatory agents. These molecules promote neurogenesis, synaptogenesis, and myelination, processes critical to brain maturation during the neonatal period. Pasteurization, while necessary for safety, may reduce some of these factors, yet donor milk still retains substantial activity compared to formula.

The implications of this research extend beyond immediate neonatal care. Long-term neurodevelopmental outcomes are significantly influenced by early brain structure integrity, affecting cognitive functions including memory, attention, and executive functions. Enhancing brain development through optimal nutrition opens avenues for reducing the burden of neurodevelopmental disabilities commonly observed in preterm populations.

Moreover, this study underscores the importance of expanding donor milk programs in NICUs, advocating for policy shifts to prioritize human milk availability when maternal lactation is insufficient. Current barriers, including logistic challenges, cost, and supply limitations, must be addressed to maximize the benefit for preterm infants globally.

Future research directions highlighted by the authors include longitudinal studies tracking neurodevelopmental progress into childhood and adolescence, exploring whether the structural advantages observed translate into measurable cognitive and behavioral improvements. Additionally, investigating optimization of donor milk processing to preserve bioactive components may further augment its neuroprotective capacity.

Advanced neuroimaging serves as an indispensable tool in neonatal research, bridging clinical observations with mechanistic understanding. By elucidating the nuanced influence of nutrition on brain architecture, studies like this guide interventions targeting the earliest windows of neuroplasticity, when therapeutic efforts are most impactful.

In conclusion, this pivotal research confirms that donor human milk is not merely a nutritional alternative but a critical contributor to enhanced brain development in very preterm infants. Its use correlates with measurable improvements in brain structure, setting a precedent for refining neonatal nutritional protocols to support optimal brain health outcomes.

As the landscape of neonatal care evolves, integrating such evidence-driven approaches ensures that vulnerable preterm infants receive the best foundation for neurodevelopment. The study serves as a clarion call to clinicians, researchers, and policymakers alike, emphasizing the profound significance of early-life nutritional interventions in shaping lifelong neurological trajectories.

The findings resonate deeply amidst ongoing efforts to mitigate the lifelong challenges faced by preterm infants. With more widespread implementation, donor human milk feeding protocols could fundamentally alter the developmental prospects for millions of infants worldwide, heralding a new era in neonatal neuroprotection rooted in the power of human milk.

Subject of Research: The impact of donor human milk on structural brain development in very preterm infants.

Article Title: Donor human milk and structural brain development in very preterm infants.

Article References:
Ottolini, K.M., Basu, S.K., Ngwa, J. et al. Donor human milk and structural brain development in very preterm infants. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04539-3

DOI: https://doi.org/10.1038/s41390-025-04539-3

Preterm infants, born before full maturation of their gastrointestinal and immune systems, are especially vulnerable to conditions such as necrotizing enterocolitis (NEC) and sepsis. The establishment of a healthy gut microbiota in these neonates is a critical determinant of risk reduction for such life-threatening conditions. Human milk—from the infant’s own mother or donor milk—is considered the gold standard for feeding preterm infants due to its unique bioactive components, immunological factors, and essential nutrients. However, donor milk must undergo processing to ensure microbiological safety, predominantly through pasteurization, which can inadvertently alter its beneficial properties.

The study at hand delves into two principal pasteurization methods: Holder pasteurization, which involves heating milk to 62.5°C for 30 minutes, and high-temperature short-time (HTST) pasteurization, which rapidly heats milk to 72°C for 15 seconds. While Holder pasteurization has been the traditional and widely implemented standard in milk banks worldwide, emerging evidence suggests that HTST and other novel techniques may better preserve the functional and microbiological integrity of human milk. Yet, their direct effects on the neonatal gut microbiome remained inadequately characterized until now.

By systematically analyzing stool samples from preterm infants fed with milk subjected to either Holder or HTST pasteurization, the research team employed advanced metagenomic sequencing tools to map the complex communities of bacterial taxa colonizing the infants’ gastrointestinal tracts. The investigators discovered striking differences: infants receiving HTST-pasteurized milk showed significantly increased microbial diversity, with a richer abundance of beneficial genera such as Bifidobacterium and Lactobacillus, organisms known to support gut barrier function and modulate immune responses.

These findings highlight that HTST processing preserves more of the milk’s bioactive molecules and endogenous microbiota, elements believed to foster a more favorable microbial colonization. Conversely, the Holder method, although efficacious at eliminating pathogens, may lead to a depletion of these critical components, potentially resulting in a less diverse and more pathogen-prone microbiome. This could, in turn, explain the observed clinical discrepancies in infant outcomes related to feeding regimens that rely exclusively on Holder-pasteurized milk.

The implications transcend microbiology alone. A richer gut microbiome, nurtured by less disruptive milk pasteurization, is intricately tied to improved nutrient absorption, maturation of the immune system, and reduced incidence of inflammatory diseases in preterm infants. Such outcomes align with the overarching goal of neonatal care: to replicate, as closely as possible, the protective environment of the womb, thereby minimizing the vulnerabilities imposed by premature birth.

The research also meticulously measures critical milk components—such as immunoglobulins, enzymes, and growth factors—before and after pasteurization. HTST methodology retains higher levels of these molecules, reinforcing the notion that rapid heating serves as a gentle yet effective microbial inactivation strategy. The preserved biologically active proteins likely act synergistically with the microbial populations to foster an optimal intestinal milieu conducive to health.

Technological advancements in human milk processing thus stand at a pivotal crossroads. The laborious rigor traditionally associated with Holder pasteurization ensured safety but perhaps at the expense of efficacy. The study underscores a paradigm shift advocating for integration of HTST or other innovative methods, potentially transforming standard operating procedures at milk banks and neonatal units worldwide.

Clinicians and neonatologists stand to benefit immensely from these discoveries, as optimized donor milk could serve as a powerful intervention tool. Enhanced microbial diversity in the gut correlates with lower risks of sepsis and NEC, conditions that carry profound morbidity and mortality. Personalized nutrition based on refined milk preparation could ultimately improve neurodevelopmental outcomes through the gut-brain axis, an increasingly validated concept linking early microbiota composition with cognitive trajectories.

Moreover, the researchers propose that future studies should investigate the long-term impacts of these microbial shifts beyond the neonatal period, encompassing infancy and childhood development. Longitudinal tracking of immune markers and growth parameters would provide further clarity on the lasting benefits of improved pasteurization techniques. Such comprehensive approaches will be essential in establishing evidence-based guidelines consolidating the role of donor milk processing in neonatal care.

Critically, the study’s robust methodology, encompassing rigorous sequencing, biochemical assays, and clinical correlation, sets a new benchmark for neonatal nutrition research. Its pioneering approach blends microbiology, biochemistry, and clinical science, reflecting the interdisciplinary nature of tackling prematurity-associated challenges.

The global burden of preterm birth necessitates innovative strategies that extend beyond survival to thriving. Human milk is integral to this mission. Fine-tuning how donor milk is processed could be a simple yet monumental step in safeguarding the health of the most vulnerable infants.

As milk banking infrastructures adapt, incorporating HTST pasteurization protocols may become more feasible with technological advancements lowering operational costs and improving scalability. Widespread adoption can potentially democratize access to superior-quality donor human milk, especially in regions where maternal lactation is compromised or insufficient.

This transformative research thus opens new horizons, uniting science and clinical practice with compassionate care. While ensuring safety remains paramount, optimizing nutritive and immunological properties through refined pasteurization offers an unprecedented opportunity to harness the full potential of donor human milk.

In conclusion, this landmark study by Ocampo-Chih and colleagues represents a critical leap forward in understanding the complex interactions between milk processing methods and the neonatal gut microbiome. By demonstrating that HTST pasteurization better preserves microbial diversity and bioactive constituents compared to the traditional Holder technique, the findings chart a course toward improved neonatal outcomes globally. The compelling evidence calls for reevaluation of current milk banking standards and underscores the importance of continuing research on nutrition-based interventions in preterm infant care.

Subject of Research: The impact of donor human milk pasteurization methods on the gut microbiome composition and diversity in preterm infants.

Article Title: Impact of donor human milk pasteurization methods on the gut microbiome of preterm infants.

Article References:
Ocampo-Chih, C., Hendricks, H., Weitkamp, S. et al. Impact of donor human milk pasteurization methods on the gut microbiome of preterm infants. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04386-2

DOI: https://doi.org/10.1038/s41390-025-04386-2